drugset / Trial / NCT02805257
Ahmed Glaucoma Valve Surgery With Mitomycin-C
Phase 2
Completed
119 enrolled
University of California, San Francisco
Asociación para Evitar la Ceguera en México · collabBascom Palmer Eye Institute · collabHospital Central Militar · collabShri Ganesh Vinayak Eye Hospital · collabUniversity of Colorado, Denver · collabUniversity of Maryland · collabUniversity of North Carolina · collabZhongshan Ophthalmic Center, Sun Yat-sen University · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
Timeline
- Start
- 2016-06
- Primary completion
- 2020-03
- Completion
- 2020-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitomycin C | Other / unclassified | 0.1 ml | Other |
| Subject | Mitomycin C | Other / unclassified | 0.4 mg/ml | Other |